Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1.15B
-
Number of holders
-
815
-
Total 13F shares, excl. options
-
522M
-
Shares change
-
+6.49M
-
Total reported value, excl. options
-
$32.5B
-
Value change
-
+$494M
-
Put/Call ratio
-
0.61
-
Number of buys
-
341
-
Number of sells
-
-357
-
Price
-
$62.30
Significant Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q1 2015
934 filings reported holding TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share as of Q1 2015.
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) has 815 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 522M shares
of 1.15B outstanding shares and own 45.49% of the company stock.
Largest 10 shareholders include FMR LLC (56.1M shares), FRANKLIN RESOURCES INC (55M shares), Invesco Ltd. (22.1M shares), LAZARD ASSET MANAGEMENT LLC (20.1M shares), WADDELL & REED FINANCIAL INC (17.2M shares), Allianz Asset Management AG (11.4M shares), NORGES BANK (10.5M shares), Mondrian Investment Partners LTD (10.5M shares), PointState Capital LP (10.3M shares), and BARROW HANLEY MEWHINNEY & STRAUSS LLC (10.2M shares).
This table shows the top 815 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.